Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
Aon
AON
|
+$1.04B |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$901M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$823M |
| 5 |
Pinduoduo
PDD
|
+$770M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.19B |
| 2 |
Datadog
DDOG
|
+$747M |
| 3 |
TSMC
TSM
|
+$707M |
| 4 |
Baxter International
BAX
|
+$703M |
| 5 |
Estee Lauder
EL
|
+$592M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.28% |
| 2 | Healthcare | 10.85% |
| 3 | Financials | 9.94% |
| 4 | Consumer Discretionary | 8.39% |
| 5 | Industrials | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4926
Aura Biosciences
AURA
$826M
| $674K | ﹤0.01% |
72,593
+7,990
| +12% | +$83K |
|
|
TCFC
4927
DELISTED
The Community Financial Corporation Common Stock
TCFC
| $670K | ﹤0.01% |
20,232
+7,163
| +55% | +$277K |
|
4928
Praxis Precision Medicines
PRAX
$10.1B
| $670K | ﹤0.01% |
55,236
+43,099
| +355% | +$1.82M |
|
4929
Phathom Pharmaceuticals
PHAT
$692M
| $669K | ﹤0.01% |
93,698
+24,510
| +35% | +$215K |
|
4930
NewtekOne
NEWT
$391M
| $669K | ﹤0.01% |
52,247
-8,742
| -14% | -$144K |
|
|
TEAD
4931
Teads Holding Co
TEAD
$67.7M
| $668K | ﹤0.01% |
161,730
+51,844
| +47% | +$235K |
|
4932
Custom Truck One Source
CTOS
$2.37B
| $668K | ﹤0.01% |
98,351
+16,754
| +21% | +$116K |
|
4933
Sutro Biopharma
STRO
$421M
| $667K | ﹤0.01% |
14,442
-8,351
| -37% | -$530K |
|
|
MACK
4934
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $666K | ﹤0.01% |
54,160
+44,997
| +491% | +$529K |
|
4935
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$305M
| $663K | ﹤0.01% |
23,718
+13,173
| +125% | +$386K |
|
4936
CVRx
CVRX
$63.4M
| $663K | ﹤0.01% |
71,127
+56,179
| +376% | +$743K |
|
|
PTRA
4937
DELISTED
Proterra Inc. Common Stock
PTRA
| $662K | ﹤0.01% |
435,352
-146,118
| -25% | -$550K |
|
|
MFD
4938
DELISTED
Macquarie/First Trust Global Infrastructure/Utilities Dividend & Income Fund
MFD
| $661K | ﹤0.01% |
79,975
-1,634
| -2% | -$13.6K |
|
4939
Deswell Industries
DSWL
$52.1M
| $660K | ﹤0.01% |
249,169
-5,200
| -2% | -$15.4K |
|
4940
First Business Financial Services
FBIZ
$595M
| $660K | ﹤0.01% |
21,642
-1,310
| -6% | -$44.9K |
|
4941
Rigel Pharmaceuticals
RIGL
$750M
| $660K | ﹤0.01% |
49,981
-10,512
| -17% | -$167K |
|
4942
Tiptree Inc
TIPT
$675M
| $655K | ﹤0.01% |
44,980
+21,715
| +93% | +$330K |
|
4943
Mistras Group
MG
$512M
| $655K | ﹤0.01% |
96,654
+17,858
| +23% | +$97.8K |
|
4944
Oil-Dri
ODC
$1.34B
| $655K | ﹤0.01% |
31,462
+14,932
| +90% | +$276K |
|
4945
Third Coast Bancshares
TCBX
$738M
| $654K | ﹤0.01% |
41,642
+1,547
| +4% | +$27.7K |
|
4946
Daktronics
DAKT
$1.04B
| $652K | ﹤0.01% |
114,907
+87,268
| +316% | +$356K |
|
|
LVOX
4947
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
| $651K | ﹤0.01% |
210,655
-783
| -0.4% | -$2.08K |
|
4948
Global X Guru Index ETF
GURU
$63.5M
| $649K | ﹤0.01% |
18,463
-2,084
| -10% | -$74.1K |
|
4949
ARS Pharmaceuticals
SPRY
$612M
| $648K | ﹤0.01% |
99,606
+10,392
| +12% | +$79.8K |
|
|
IAF
4950
abrdn Australia Equity Fund
IAF
$127M
| $648K | ﹤0.01% |
49,198
+9,064
| +23% | +$127K |
|
Similar funds
Morgan Stanley's Q1 2023 Portfolio in Review
As of Q1 2023, Morgan Stanley held 8,043 positions worth $933B, up 5.9% from $880B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q1 2023 filing shows 163 new, 3,525 increased, 3,121 reduced and 300 closed positions. Its largest new stake was Calvert US Large-Cap Diversity, Equity and Inclusion Index ETF: 400,000 shares worth $20.8M. The largest sale was Apple, an estimated $1.19B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q1 2023 buy was Calvert US Large-Cap Diversity, Equity and Inclusion Index ETF: 400,000 shares worth $20.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $1.62B increase.
- Morgan Stanley's biggest Q1 2023 reduction was Apple, cutting an estimated $1.19B.
- Morgan Stanley fully exited SVB Financial Group in Q1 2023, selling an estimated $354M.
- Morgan Stanley's ten largest holdings make up 16% of its $933B portfolio in Q1 2023.
- Morgan Stanley opened 163 new positions and closed 300 in Q1 2023.
- Morgan Stanley's portfolio value rose 5.9% quarter-over-quarter to $933B.
Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.